Jean-Philippe Carralot

Title: Innovations of Jean-Philippe Carralot

Introduction

Jean-Philippe Carralot is a notable inventor based in Saint-Louis, France. He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Carralot's work focuses on developing advanced therapeutic solutions.

Latest Patents

Carralot's latest patents include "Immune antigen specific IL-18 immunocytokines and uses thereof." This patent relates to modified immunocytokine compositions that comprise antibodies or antigen binding fragments specific for immune cell antigens and IL-18 polypeptides. The disclosure also includes methods of treatment and manufacture of these immunocytokine compositions. Another significant patent is "Modified TNF-α antibodies and uses thereof." This patent discusses modified anti-TNFα polypeptides, their compositions, and methods for treating inflammatory disorders using these modified polypeptides.

Career Highlights

Carralot is currently associated with Bright Peak Therapeutics AG, where he continues to push the boundaries of immunotherapy. His work is instrumental in developing treatments that target specific immune responses, which can lead to more effective therapies for various diseases.

Collaborations

Carralot collaborates with esteemed colleagues such as Vijaya Raghavan Pattabiraman and Bertolt Kreft. Their combined expertise enhances the innovative potential of their projects and contributes to the advancement of therapeutic solutions.

Conclusion

Jean-Philippe Carralot's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new treatments that can significantly impact patient care.